SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCATO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.020
AS - Asia 3.649
EU - Europa 2.656
SA - Sud America 634
AF - Africa 81
OC - Oceania 21
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.885
SG - Singapore 1.415
CN - Cina 1.221
PL - Polonia 598
BR - Brasile 565
IT - Italia 472
DE - Germania 433
UA - Ucraina 335
HK - Hong Kong 305
GB - Regno Unito 211
TR - Turchia 195
VN - Vietnam 152
FI - Finlandia 143
SE - Svezia 115
RU - Federazione Russa 105
ID - Indonesia 81
IN - India 73
CA - Canada 66
FR - Francia 64
MX - Messico 56
NL - Olanda 45
AR - Argentina 36
ZA - Sudafrica 34
BD - Bangladesh 33
JP - Giappone 28
ES - Italia 25
PK - Pakistan 24
BE - Belgio 19
IR - Iran 19
CZ - Repubblica Ceca 18
LT - Lituania 16
AU - Australia 15
AT - Austria 13
EC - Ecuador 13
IQ - Iraq 13
GR - Grecia 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
MY - Malesia 10
KR - Corea 9
VE - Venezuela 8
MA - Marocco 7
TN - Tunisia 7
CH - Svizzera 6
CO - Colombia 6
LY - Libia 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
AZ - Azerbaigian 5
IL - Israele 5
JO - Giordania 5
KE - Kenya 5
RO - Romania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
NG - Nigeria 4
PH - Filippine 4
TW - Taiwan 4
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
KZ - Kazakistan 3
YE - Yemen 3
AL - Albania 2
CL - Cile 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
Totale 13.059
Salva come PNG Salva come JPEG
Città #
Singapore 770
Ashburn 625
Warsaw 594
Woodbridge 573
Beijing 472
Chandler 411
Fairfield 407
Jacksonville 381
Santa Clara 336
Houston 312
Hong Kong 304
Ann Arbor 296
Wilmington 182
Seattle 142
Ferrara 136
Nanjing 135
New York 122
Cambridge 120
Munich 117
Izmir 114
Los Angeles 107
Dallas 95
Princeton 91
Bologna 69
Boardman 65
Shanghai 62
Addison 61
Jakarta 59
Bremen 55
Turku 52
Milan 51
Ho Chi Minh City 50
Shenyang 42
Redwood City 41
Hefei 39
San Diego 39
Mexico City 36
São Paulo 35
Hanoi 32
Brooklyn 27
Rio de Janeiro 27
Nanchang 26
Jiaxing 24
London 23
Moscow 23
Tianjin 23
Toronto 23
Dearborn 22
Falkenstein 22
Jinan 22
Changsha 21
Tokyo 21
Chennai 20
Hebei 20
Auburn Hills 19
Denver 19
Brussels 18
Chicago 18
San Francisco 18
Ferrara di Monte Baldo 17
Johannesburg 17
Orem 17
Belo Horizonte 16
Stockholm 16
Atlanta 15
Buffalo 15
Falls Church 15
Brasília 14
Dong Ket 14
Montreal 14
Mountain View 14
Phoenix 14
San Jose 14
Curitiba 13
Guangzhou 13
Helsinki 13
Leiden 13
Poplar 13
The Dalles 13
Boston 12
Brno 12
Zhengzhou 12
Frankfurt am Main 11
Manchester 11
Norwalk 11
Ningbo 10
Ankara 9
Sydney 9
Varese 9
Verona 9
Fars 8
Indiana 8
Kunming 8
Porto Alegre 8
Washington 8
Biên Hòa 7
Buenos Aires 7
Charlotte 7
Des Moines 7
Dhaka 7
Totale 8.546
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 384
A validated cellular biobank for β-thalassemia 364
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 315
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 313
A validated THALAMOSS cellular biobank for β-thalassemia 291
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 246
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 241
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 229
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 207
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 189
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 188
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 183
Structure and Biological Activity of Furocoumarins 178
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 177
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 170
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 166
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 163
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 163
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia 162
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 156
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 155
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 152
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 150
Erythroid Induction of Chronic Myelogenous Leukemia K562 Cells Following Treatment with a Photoproduct Derived from the UV-A Irradiation of 5-Methoxypsoralen 149
Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives 146
Cellular biosensors for the identification of fetal hemoglobin inducers 145
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 145
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 144
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 144
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 142
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin 142
Development and molecular characterization of transgenic mice for beta-thalassemia 140
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 138
Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives 138
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 134
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 132
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 131
Gene therapy combined with HbF induction in beta-thalassemia 131
Involvement of miRNA in erythroid differentiation 130
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 130
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 127
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 126
Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters 125
Targeting the miR-221/miR-222 cluster in cancer therapy 123
Recent trends in the gene therapy of β-thalassemia 120
Gene therapy and fetal hemoglobin induction 117
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 116
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 115
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 115
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 114
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 113
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 112
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 109
Everolimus is a potent inducer of erythroid differentation and gamma-globin gene expression in human erythroid cells 107
null 107
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 106
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 104
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 104
Evidences for miRNA regulation of BCL11A gene expression 104
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 104
null 103
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 102
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 102
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 101
Mithramycin-mediated induction of K562 cell erythroid differentiation is associated with inhibition of the mTOR-CI patway 99
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 98
Readthrough of the premature stop codon beta039-thalassemia 97
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 97
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 96
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 96
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 95
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 94
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic 93
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 93
Production of a cellular model for the screening of inducers of fetal haemoglobin 92
Increase of accumulationof gamma-globin mRNA in human erythroid cells treated with psoralens 91
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 91
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 90
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 88
null 87
null 85
Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations 83
Sex-specific transcriptional profiles identified in β-thalassemia patients 83
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 82
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 82
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences 81
Novel biological activity of psoralens. Induction of accumulation of g-globin mRNA in human erythroid cells 79
Erythroid differentiation induced by mithramycin in K562 cells is associated with inhibition of the mTOR-C1 pathway 77
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 76
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 75
null 75
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 74
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 74
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 71
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 67
Ultra sensitive plasmonic devices for early cancer diagnosis 65
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 62
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 59
null 52
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 52
Totale 12.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 612
Totale 63.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021840 0 0 0 0 0 126 58 135 35 155 213 118
2021/2022852 87 77 37 25 50 42 46 37 23 80 85 263
2022/2023958 95 91 23 125 174 129 72 82 81 8 42 36
2023/2024673 34 103 27 17 82 124 78 45 10 8 16 129
2024/20252.395 74 57 201 141 270 189 73 104 387 308 317 274
2025/20263.286 634 285 483 758 900 226 0 0 0 0 0 0
Totale 13.322